Magnesium and its transporters in cancer: A novel paradigm in tumour development

Clinical Science

Volumn 123, Issue 7, 2012, Pages 417-427

  Wolf, Federica I ^a   Trapani, Valentina ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Aerobic glycolysis; Apoptosis; Metabolism; Mitochondrial RNA splicing 2 (mrs2); transient receptor potential melastatin 7 (TRPM7); transient receptor potential melastatin6 (TRPM6)

Indexed keywords

CETUXIMAB; MAGNESIUM; PANITUMUMAB; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7;

ANGIOGENESIS; APOPTOSIS; CANCER PATIENT; CARCINOGENESIS; CELL PROLIFERATION; HUMAN; HYPOMAGNESEMIA; METABOLIC PARAMETERS; METASTASIS; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH;

ANIMALS; HUMANS; MAGNESIUM; NEOPLASMS; TRPM CATION CHANNELS;

EID: 84864021130     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120086     Document Type: Review

References (104)

1. Wolf, F. I. and Trapani, V. (2008) Cell (patho)physiology of magnesium. Clin. Sci. 114, 27-35
2. 2- in the regulation of protein synthesis and cell proliferation: significance for neoplastic transformation. Adv. Cancer Res. 93, 1-58
3. Lameire, N., Van Biesen, W. and Vanholder, R. (2010) Electrolyte disturbances and acute kidney injury in patients with cancer. Semin. Nephrol. 30, 534-547
4. Lajer, H. and Daugaard, G. (1999) Cisplatin and hypomagnesemia. Cancer Treat. Rev. 25, 47-58
5. Tejpar, S., Piessevaux, H., Claes, K., Piront, P., Hoenderop, J. G., Verslype, C. and Van Cutsem, E. (2007) Magnesium wasting associated with epidermal-growthfactor receptor-targeting antibodies in colorectal cancer: a prospective study. Lancet Oncol. 8, 387-394
6. Groenestege, W. M., Thébault, S., van der Wijst, J., van den Berg, D., Janssen, R., Tejpar, S., van den Heuvel, L. P., van Cutsem, E., Hoenderop, J. G., Knoers, N. V. and Bindels, R. J. (2007) Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J. Clin. Invest. 117, 2260-2267
7. Schrag, D., Chung, K. Y., Flombaum, C. and Saltz, L. (2005) Cetuximab therapy and symptomatic hypomagnesemia. J. Natl. Cancer Inst. 97, 1221-1224
8. Vincenzi, B., Santini, D. and Tonini, G. (2008) Biological interaction between anti-epidermal growth factor receptor agent cetuximab and magnesium. Expert Opin. Pharmacother. 9, 1267-1269
9. Vincenzi, B., Santini, D., Galluzzo, S., Russo, A., Fulfaro, F., Silletta, M., Battistoni, F., Rocci, L., Zobel, B. B., Adamo, V. et al. (2008) Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome. Clin. Cancer Res. 14, 4219-4224
10. Vincenzi, B., Galluzzo, S., Santini, D., Rocci, L., Loupakis, F., Correale, P., Addeo, R., Zoccoli, A., Napolitano, A., Graziano, F. et al. (2011) Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients. Ann. Oncol. 22, 1141-1146
11. Wolf, F. I., Maier, J. A., Nasulewicz, A., Feillet-Coudray, C., Simonacci, M., Mazur, A. and Cittadini, A. (2007) Magnesium and neoplasia: from carcinogenesis to tumor growth and progression or treatment. Arch. Biochem. Biophys. 458, 24-32
12. Hartwig, A. (2001) Role of magnesium in genomic stability. Mutat. Res. 475, 113-121
13. Wolf, F. I. (2010) Response to the letter to the editor. Magnes. Res. 23, 59
14. Wolf, F. I., Cittadini, A. R. and Maier, J. A. (2009) Magnesium and tumors: ally or foe? Cancer Treat. Rev. 35, 378-382
15. Hanahan, D. and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
16. Hanahan, D. andWeinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70
17. Castiglioni, S. and Maier, J. A. (2011) Magnesium and cancer: a dangerous liason. Magnes. Res. 24, S92-S100
18. Baldoli, E. and Maier, J. A. (2012) Silencing TRPM7 mimics the effects of magnesium deficiency in human microvascular endothelial cells. Angiogenesis 15, 47-57
19. Ferré, S., Baldoli, E., Leidi, M. and Maier, J. A. (2010) Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFκB. Biochim. Biophys. Acta 1802, 952-958
20. Maier, J. A., Nasulewicz-Goldeman, A., Simonacci, M., Boninsegna, A., Mazur, A. and Wolf, F. I. (2007) Insights into the mechanisms involved in magnesium-dependent inhibition of primary tumor growth. Nutr. Cancer 59, 192-198
21. Nasulewicz, A., Wietrzyk, J., Wolf, F. I., Dzimira, S., Madej, J., Maier, J. A., Rayssiguier, Y., Mazur, A. and Opolski, A. (2004) Magnesium deficiency inhibits primary tumor growth but favors metastasis in mice. Biochim. Biophys. Acta 1739, 26-32
22. Mazur, A., Maier, J. A., Rock, E., Gueux, E., Nowacki, W. and Rayssiguier, Y. (2007) Magnesium and the inflammatory response: potential physiopathological implications. Arch. Biochem. Biophys. 458, 48-56
23. Kim, D. J., Xun, P., Liu, K., Loria, C., Yokota, K., Jacobs, Jr, D. R. and He, K. (2010) Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 33, 2604-2610
24. de Oliveira Otto, M. C., Alonso, A., Lee, D. H., Delclos, G. L., Jenny, N. S., Jiang, R., Lima, J. A., Symanski, E., Jacobs, Jr, D. R. and Nettleton, J. A. (2011) Dietary micronutrient intakes are associated with markers of inflammation but not with markers of subclinical atherosclerosis. J. Nutr. 141, 1508-1515
25. Colotta, F., Allavena, P., Sica, A., Garlanda, C. and Mantovani, A. (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073-1081
26. Solinas, G., Marchesi, F., Garlanda, C., Mantovani, A. and Allavena, P. (2010) Inflammation-mediated promotion of invasion and metastasis. Cancer Metastasis Rev. 29, 243-248
27. Covacci, V., Bruzzese, N., Sgambato, A., Di Francesco, A., Russo, M. A., Wolf, F. I. and Cittadini, A. (1998) Magnesium restriction induces granulocytic differentiation and expression of p27Kip1 in human leukemic HL-60 cells. J. Cell. Biochem. 70, 313-322
28. Sgambato, A., Wolf, F. I., Faraglia, B. and Cittadini, A. (1999) Magnesium depletion causes growth inhibition, reduced expression of cyclin D1, and increased expression of p27Kip1 in normal but not in transformed mammary epithelial cells. J. Cell. Physiol. 180, 245-254
29. Ferr'e, S., Mazur, A. and Maier, J. A. (2007) Low-magnesium induces senescent features in cultured human endothelial cells. Magnes. Res. 20, 66-71
30. Killilea, D. W. and Ames, B. N. (2008) Magnesium deficiency accelerates cellular senescence in cultured human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 105, 5768-5773
31. Wolf, F. I., Trapani, V., Simonacci, M., Boninsegna, A., Mazur, A. and Maier, J. A. (2009) Magnesium deficiency affects mammary epithelial cell proliferation: involvement of oxidative stress. Nutr. Cancer 61, 131-136
32. Wolf, F. I., Fasanella, S., Tedesco, B., Torsello, A., Sgambato, A., Faraglia, B., Palozza, P., Boninsegna, A. and Cittadini, A. (2004) Regulation of magnesium content during proliferation of mammary epithelial cells (HC-11). Front. Biosci. 9, 2056-2062
33. Rubin, H. (1975) Central role for magnesium in coordinate control of metabolism and growth in animal cells. Proc. Natl. Acad. Sci. U.S.A. 72, 3551-3555
34. Rubin, H. (2007) The logic of the Membrane, Magnesium, Mitosis (MMM) model for the regulation of animal cell proliferation. Arch. Biochem. Biophys. 458, 16-23
35. Sahni, J. and Scharenberg, A. M. (2008) TRPM7 ion channels are required for sustained phosphoinositide 3-kinase signaling in lymphocytes. Cell Metab. 8, 84-93
36. Sahni, J., Tamura, R., Sweet, I. R. and Scharenberg, A. M. (2010) TRPM7 regulates quiescent/proliferative metabolic transitions in lymphocytes. Cell Cycle 9, 3565-3574
37. Ikari, A., Okude, C., Sawada, H., Yamazaki, Y., Sugatani, J. and Miwa, M. (2008) TRPM6 expression and cell proliferation are up-regulated by phosphorylation of ERK1/2 in renal epithelial cells. Biochem. Biophys. Res. Commun. 369, 1129-1133
38. Ikari, A., Sanada, A., Okude, C., Sawada, H., Yamazaki, Y., Sugatani, J. and Miwa, M. (2010) Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells. J. Cell. Physiol. 222, 481-487
39. Ikari, A., Sanada, A., Sawada, H., Okude, C., Tonegawa, C. and Sugatani, J. (2011) Decrease in transient receptor potential melastatin 6 mRNA stability caused by rapamycin in renal tubular epithelial cells. Biochim. Biophys. Acta 1808, 1502-1508
40. (1936) On the origin of cancer cells
41. Cowan, J. A. (1995) The Biological Chemistry of Magnesium, VCH Publishers, New York
42. Romani, A. (2007) Regulation of magnesium homeostasis and transport in mammalian cells. Arch. Biochem. Biophys. 458, 90-102
43. Barbagallo, M. and Dominguez, L. J. (2007) Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch. Biochem. Biophys. 458, 40-47
44. Cairns, R. A., Harris, I. S. and Mak, T.W. (2011) Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85-95
45. Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M. and Cantley, L. C. (2008) Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452, 181-186
46. Barbagallo, M. and Dominguez, L. J. (2010) Magnesium and aging. Curr. Pharm.Des. 16, 832-839
47. Romero-Garcia, S., Lopez-Gonzalez, J. S., Báez-Viveros, J. L., Aguilar-Cazares, D. and Prado-Garcia, H. (2011) Tumor cell metabolism: an integral view. Cancer Biol. Ther. 12, 939-948
48. Aarts, M., Iihara, K., Wei, W. L., Xiong, Z. G., Arundine, M., Cerwinski, W., MacDonald, J. F. and Tymianski, M. (2003) A key role for TRPM7 channels in anoxic neuronal death. Cell 115, 863-877
49. Zhang, J., Zhao, F., Zhao, Y., Wang, J., Pei, L., Sun, N. and Shi, J. (2011) Hypoxia induces an increase in intracellular magnesium via transient receptor potential melastatin 7 (TRPM7) channels in rat hippocampal neurons in vitro. J. Biol. Chem. 286, 20194-20207
50. Wouters, B. G. and Koritzinsky, M. (2008) Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat. Rev. Cancer 8, 851-864
51. Rodríguez-Enríquez, S., Gallardo-Pérez, J. C., Marín-Hernández, A. and Moreno-Sánchez, R. (2012) TheWarburg hypothesis and the ATP supply in cancer cells: is oxidative phosphorylation impaired in malignant neoplasias? Curr. Pharm. Biotechnol., in the press
52. Chen, J. L., Lucas, J. E., Schroeder, T., Mori, S., Wu, J., Nevins, J., Dewhirst, M., West, M. and Chi, J. T. (2008) The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet. 4, e1000293
53. Patel, T., Bronk, S. F. and Gores, G. J. (1994) Increases of intracellular magnesium promote glycodeoxycholateinduced apoptosis in rat hepatocytes. J. Clin. Invest. 94, 2183-2192
54. Chien, M. M., Zahradka, K. E., Newell, M. K. and Freed, J. H. (1999) Fas-induced B cell apoptosis requires an increase in free cytosolic magnesium as an early event. J. Biol. Chem. 274, 7059-7066
55. Zhang, X. Y., Li, W. G., Wu, Y. J., Bai, D. C. and Liu, N. F. (2005) Proanthocyanidin from grape seeds enhances doxorubicin-induced antitumor effect and reverses drug resistance in doxorubicin-resistant K562/DOX cells. Can. J. Physiol. Pharmacol. 83, 309-318
56. Kubota, T., Shindo, Y., Tokuno, K., Komatsu, H., Ogawa, H., Kudo, S., Kitamura, Y., Suzuki, K. and Oka, K. (2005) Mitochondria are intracellular magnesium stores: investigation by simultaneous fluorescent imagings in PC12 cells. Biochim. Biophys. Acta 1744, 19-28
57. Shindo, Y., Fujimoto, A., Hotta, K., Suzuki, K. and Oka, K. (2010) Glutamate-induced calcium increase mediates magnesium release from mitochondria in rat hippocampal neurons. J. Neurosci. Res. 88, 3125-3132
58. Zsurka, G., Gregán, J. and Schweyen, R. J. (2001) The human mitochondrial Mrs2 protein functionally substitutes for its yeast homologue, a candidate magnesium transporter. Genomics 72, 158-168
59. 2+ influx system in mitochondria. EMBO J. 22, 1235-1244
60. Piskacek, M., Zotova, L., Zsurka, G. and Schweyen, R. J. (2009) Conditional knockdown of hMRS2 results in loss of mitochondrial Mg2+ uptake and cell death. J. Cell. Mol. Med. 13, 693-700
61. Chen, Y., Wei, X., Yan, P., Han, Y., Sun, S., Wu, K. and Fan, D. (2009) Human mitochondrial Mrs2 protein promotes multidrug resistance in gastric cancer cells by regulating p27, cyclin D1 expression and cytochrome c release. Cancer Biol. Ther. 8, 607-614
62. Wolf, F. I. and Trapani, V. (2009) Multidrug resistance phenotypes and MRS2 mitochondrial magnesium channel: two players from one stemness? Cancer Biol. Ther. 8, 615-617
63. Bernardi, P., Vassanelli, S., Veronese, P., Colonna, R., Szab ó, I. and Zoratti, M. (1992) Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J. Biol. Chem. 267, 2934-2939
64. Evtodienko, Y. V., Teplova, V. V., Azarashvily, T. S., Virtanen, I. and Saris, N. L. (1999) Mechanisms of the resistance to the mitochondrial permeability transition in tumour cells. Pathophysiology 6, 171-178
65. Marverti, G., Ligabue, A., Montanari, M., Guerrieri, D., Cusumano, M., Di Pietro, M. L., Troiano, L., Di Vono, E., Iotti, S., Farruggia, G. et al. (2011) Characterization of the cell growth inhibitory effects of a novel DNAintercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and -resistant human ovarian cancer cells. Invest. New Drugs 29, 73-86
66. Schlingmann, K. P., Waldegger, S., Konrad, M., Chubanov, V. and Gudermann, T. (2007) TRPM6 and TRPM7: gatekeepers of human magnesium metabolism. Biochim. Biophys. Acta 1772, 813-821
67. 2+ homeostasis by TRPM7. Cell 114, 191-200
68. 2+ homeostasis in mammals. Nat. Commun. 1, 109
69. Woudenberg-Vrenken, T. E., Sukinta, A., van der Kemp, A. W., Bindels, R. J. and Hoenderop, J. G. (2011) Transient receptor potential melastatin 6 knockout mice are lethal whereas heterozygous deletion results in mild hypomagnesemia. Nephron Physiol. 117, p11-p19
70. Elizondo, M. R., Arduini, B. L., Paulsen, J., MacDonald, E. L., Sabel, J. L., Henion, P. D., Cornell, R. A. and Parichy, D. M. (2005) Defective skeletogenesis with kidney stone formation in dwarf zebrafish mutant for trpm7. Curr. Biol. 15, 667-671
71. Walder, R. Y., Yang, B., Stokes, J. B., Kirby, P. A., Cao, X., Shi, P., Searby, C. C., Husted, R. F. and Sheffield, V. C. (2009) Mice defective in Trpm6 show embryonic mortality and neural tube defects. Hum. Mol. Genet. 18, 4367-4375
72. Jin, J., Wu, L. J., Jun, J., Cheng, X., Xu, H., Andrews, N. C. and Clapham, D. E. (2012) The channel kinase, TRPM7, is required for early embryonic development. Proc. Natl. Acad. Sci. U.S.A. 109, E225-E233
73. Liu, W., Su, L. T., Khadka, D. K., Mezzacappa, C., Komiya, Y., Sato, A., Habas, R. and Runnels, L. W. (2011) TRPM7 regulates gastrulation during vertebrate embryogenesis. Dev. Biol. 350, 348-357
74. Quamme, G. A. (2010) Molecular identification of ancient and modern mammalian magnesium transporters. Am. J. Physiol. Cell Physiol. 298, C407-C429
75. McKeehan, W. L. and Ham, R. G. (1978) Calcium and magnesium ions and the regulation of multiplication in normal and transformed cells. Nature 275, 756-758
76. Rubin, H. (1982) Differences in growth requirement and retentiveness for magnesium in nontransformed and transformed mouse 3T3 cells. Magnesium 1, 41-48
77. 2+ and Mg2+ requirements for growth are not concomitantly reduced during cell transformation. Mol. Cell. Biochem. 59, 173-181
78. Prevarskaya, N., Skryma, R. and Shuba, Y. (2010) Ion channels and the hallmarks of cancer. Trends Mol. Med. 16, 107-121
79. Prevarskaya, N., Zhang, L. and Barritt, G. (2007) TRP channels in cancer. Biochim. Biophys. Acta 1772, 937-946
80. Gkika, D. and Prevarskaya, N. (2009) Molecular mechanisms of TRP regulation in tumor growth and metastasis. Biochim. Biophys. Acta 1793, 953-958
81. Dai, Q., Shrubsole, M. J., Ness, R. M., Schlundt, D., Cai, Q., Smalley, W. E., Li, M., Shyr, Y. and Zheng, W. (2007) The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk. Am. J. Clin. Nutr. 86, 743-751
82. Zierler, S., Yao, G., Zhang, Z., Kuo, W. C., Pörzgen, P., Penner, R., Horgen, F. D. and Fleig, A. (2011)Waixenicin A inhibits cell proliferation through magnesiumdependent block of transient receptor potential melastatin 7 (TRPM7) channels. J. Biol. Chem. 286, 39328-39335
83. 2+ entry pathway in human retinoblastoma cells. J. Pharmacol. Sci. 95, 403-419
84. Yee, N. S., Zhou, W. and Liang, I. C. (2011) Transient receptor potential ion channel Trpm7 regulates exocrine pancreatic epithelial proliferation by Mg2+ -sensitive Socs3a signaling in development and cancer. Dis. Model. Mech. 4, 240-254
85. Yee, N. S., Zhou, W., Lee, M. and Yee, R. K. (2012) Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma cells. Cancer Lett. 318, 99-105
86. Guilbert, A., Gautier, M., Dhennin-Duthille, I., Haren, N., Sevestre, H. and Ouadid-Ahidouch, H. (2009) Evidence that TRPM7 is required for breast cancer cell proliferation. Am. J. Physiol. Cell Physiol. 297, C493-C502
87. Kim, B. J., Park, E. J., Lee, J. H., Jeon, J. H., Kim, S. J. and So, I. (2008) Suppression of transient receptor potential melastatin 7 channel induces cell death in gastric cancer. Cancer Sci. 99, 2502-2509
88. Jiang, J., Li, M. H., Inoue, K., Chu, X. P., Seeds, J. and Xiong, Z. G. (2007) Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation. Cancer Res. 67, 10929-10938
89. Dhennin-Duthille, I., Gautier, M., Faouzi, M., Guilbert, A., Brevet, M., Vaudry, D., Ahidouch, A., Sevestre, H. and Ouadid-Ahidouch, H. (2011) High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters. Cell. Physiol. Biochem. 28, 813-822
90. Rybarczyk, P., Gautier, M., Hague, F., Dhennin-Duthille, I., Chatelain, D., Kerr-Conte, J., Pattou, F., Regimbeau, J. M., Sevestre, H. and Ouadid-Ahidouch, H. (2012) Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration. Int. J. Cancer, doi:10.1002/ ijc.27487
91. 2+ influx. Cell Calcium 47, 425-432
92. Gao, H., Chen, X., Du, X., Guan, B., Liu, Y. and Zhang, H. (2011) EGF enhances the migration of cancer cells by up-regulation of TRPM7. Cell Calcium 50, 559-568
93. Clark, K., Langeslag, M., van Leeuwen, B., Ran, L., Ryazanov, A. G., Figdor, C. G., Moolenaar, W. H., Jalink, K. and van Leeuwen, F. N. (2006) TRPM7, a novel regulator of actomyosin contractility and cell adhesion. EMBO J. 25, 290-301
94. Wei, C., Wang, X., Chen, M., Ouyang, K., Song, L. S. and Cheng, H. (2009) Calcium flickers steer cell migration. Nature 457, 901-905
95. Abed, E. and Moreau, R. (2009) Importance of melastatin-like transient receptor potential 7 and magnesium in the stimulation of osteoblast proliferation and migration by platelet-derived growth factor. Am. J. Physiol. Cell Physiol. 297, C360-C368
96. Abed, E., Martineau, C. and Moreau, R. (2011) Role of melastatin transient receptor potential 7 channels in the osteoblastic differentiation of murine MC3T3 cells. Calcif. Tissue Int. 88, 246-253
97. Callera, G. E., He, Y., Yogi, A., Montezano, A. C., Paravicini, T., Yao, G. and Touyz, R.M. (2009) Regulation of the novel Mg2+ transporter transient receptor potential melastatin 7 (TRPM7) cation channel by bradykinin in vascular smooth muscle cells. J. Hypertens. 27, 155-166
98. Middelbeek, J., Clark, K., Venselaar, H., Huynen, M. A. and van Leeuwen, F. N. (2010) The α-kinase family: an exceptional branch on the protein kinase tree. Cell. Mol. Life Sci. 67, 875-890
99. Dorovkov, M. V., Kostyukova, A. S. and Ryazanov, A. G. (2011) Phosphorylation of annexin A1 by TRPM7 kinase: a switch regulating the induction of an α-helix. Biochemistry 50, 2187-2193
100. Clark, K., Middelbeek, J., Dorovkov, M. V., Figdor, C. G., Ryazanov, A. G., Lasonder, E. and van Leeuwen, F. N. (2008) The α-kinases TRPM6 and TRPM7, but not eEF-2 kinase, phosphorylate the assembly domain of myosin IIA, IIB and IIC. FEBS Lett. 582, 2993-2997
101. Li, F. Y., Chaigne-Delalande, B., Kanellopoulou, C., Davis, J. C., Matthews, H. F., Douek, D. C., Cohen, J. I., Uzel, G., Su, H. C. and Lenardo, M. J. (2011) Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature 475, 471-476
102. Arcangeli, A., Crociani, O., Lastraioli, E., Masi, A., Pillozzi, S. and Becchetti, A. (2009) Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr. Med. Chem. 16, 66-93
103. Kim, B. J., Kim, S. Y., Lee, S., Jeon, J. H., Matsui, H., Kwon, Y. K., Kim, S. J. and So, I. (2012) The role of transient receptor potential channel blockers in human gastric cancer cell viability. Can. J. Physiol. Pharmacol. 90, 175-186
104. Chubanov, V., Mederos, Y., Schnitzler, M., Meiner, M., Schäfer, S., Abstiens, K., Hofmann, T. and Gudermann, T. (2012) Natural and synthetic modulators of SK (Kca2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7. Br. J. Pharmacol. 166, 1357-1376